Worldwide, the number of coronavirus infections has reached close to 40 million. Trials are underway in various countries to discover the Corona vaccine. Meanwhile, the US medical device manufacturer Johnson & Johnson has currently halted the trial of the Corona vaccine. Johnson & Johnson said Monday that it is temporarily stopping the trial of the COVID-19 vaccine because one of its participants became ill.
Earlier this month, Johnson & Johnson joined the shortlist of vaccine makers in the US. Johnson & Johnson's AD26-COV2-S vaccine is the fourth such vaccine in the US to be in the final stages of clinical trials. The previous report stated that the vaccine produced a strong immune response against the coronavirus in preliminary studies. Researchers said there were no serious side effects based on the test results so far. When Johnson & Johnson began the final phase of the vaccine, the company said it included the United States, South Africa, Brazil, Vaccine will be tested on 60,000 people in Chile, Colombia, Mexico, and Peru. The news of Johnson & Johnson's vaccine trial being banned comes at a time when AstraZeneca's vaccine was banned earlier.
Oxford University and AstraZeneca's vaccine was at the forefront of the vaccine race, but Phase III trials had to be halted on September 6 when conditions worsened after some volunteers had taken the Covishield vaccine. However, there have been resumes in Britain and India. However, the US or other countries have not yet approved.